No CrossRef data available.
Article contents
Noonan syndrome associated with hypoplastic left heart syndrome
Published online by Cambridge University Press: 22 August 2022
Abstract
Noonan syndrome is an inherited disorder caused by alterations in the RAS-MAPK pathway. There have been several identified genotype–phenotype associations made with respect to congenital cardiac lesions and Noonan syndrome variants, but limited data exist regarding single ventricle disease in this population. Here, we report two patients with PTPN11-related Noonan syndrome and hypoplastic left heart syndrome variants.
- Type
- Brief Report
- Information
- Copyright
- © The Author(s), 2022. Published by Cambridge University Press
References
Roberts, AE, Allanson, JE, Tartaglia, M, Gelb, BD. Noonan syndrome. Lancet. 2013; 381: 333–342. DOI 10.1016/S0140-6736(12)61023-X.CrossRefGoogle ScholarPubMed
Pierpont, ME, Digilio, MC. Cardiovascular disease in Noonan syndrome. Curr Opin Pediatr. 2018; 30: 601–608. DOI 10.1097/MOP.0000000000000669.CrossRefGoogle ScholarPubMed
Linglart, L, Gelb, BD. Congenital heart defects in Noonan syndrome: diagnosis, management, and treatment. Am J Med Genet C Semin Med Genet. 2020; 184: 73–80. DOI 10.1002/ajmg.c.31765.CrossRefGoogle ScholarPubMed
Schulz, S, Fröber, R, Kraus, C, Schneider, U. Prenatal diagnosis of hypoplastic left heart syndrome associated with Noonan Syndrome and de novo RAF1 mutation. Prenat Diagn. 2012; 32: 1016–1018. DOI 10.1002/pd.3938.CrossRefGoogle ScholarPubMed
Tartaglia, M, Kalidas, K, Shaw, A, et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet. 2002; 70: 1555–1563. DOI 10.1086/340847.CrossRefGoogle ScholarPubMed
Digilio, MC, Romana Lepri, F, Dentici, ML, et al. Atrioventricular canal defect in patients with RASopathies. Eur J Hum Genet. 2013; 21: 200–204. DOI 10.1038/ejhg.2012.145.CrossRefGoogle ScholarPubMed
Dori, Y, Smith, C, Pinto, E, et al. Severe lymphatic disorder resolved with MEK inhibition in a patient with noonan syndrome and SOS1 mutation. Pediatrics 2020; 146: 333. DOI 10.1542/peds.2020-0167.CrossRefGoogle Scholar
Artoni, A, Selicorni, A, Passamonti, SM, et al. Hemostatic abnormalities in Noonan syndrome. Pediatrics 2014; 133: e1299–e1304. DOI 10.1542/peds.2013-3251.CrossRefGoogle ScholarPubMed
Smpokou, P, Zand, DJ, Rosenbaum, KN, Summar, ML. Malignancy in Noonan syndrome and related disorders. Clin Genet. 2015; 88: 516–522. DOI 10.1111/cge.12568.CrossRefGoogle ScholarPubMed
Andelfinger, G, Marquis, C, Raboisson, M-J, et al. Hypertrophic cardiomyopathy in Noonan Syndrome treated by MEK-inhibition. J Am Coll Cardiol. 2019; 73: 2237–2239. DOI 10.1016/j.jacc.2019.01.066.CrossRefGoogle ScholarPubMed